Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HUMAN PAPILLOMA VIRUS”

1,188 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,188 results

Testing effectiveness (Phase 2)Study completedNCT01957878
What this trial is testing

Phase II Study of HPV Therapeutic Vaccine in HPV Infected Women With Normal Cytology or ASCUS/LSIL

Who this might be right for
Genital Infection ViralHUMAN PAPILLOMA VIRUS
Genticel 239
Post-approval studies (Phase 4)Looking for participantsNCT04232917
What this trial is testing

Study of 2LPAPI® on the Clearance of Genital HR-HPV Infections.

Who this might be right for
Human Papilloma Virus
Labo'Life 284
Not applicableUnknownNCT00520078
What this trial is testing

Clinicopathological and Molecular Correlation of Acrochordon in Relation to Human Papillomavirus Infection

Who this might be right for
AcrochordonSkin TagSoft Fibroma+2 more
National Taiwan University Hospital 100
Not applicableStudy completedNCT01843478
What this trial is testing

The Self-Collection Study: a Study of Self-collected HPV Testing and Results Counseling

Who this might be right for
HIV Infection
Johns Hopkins University 97
Not applicableStudy completedNCT03628885
What this trial is testing

An Evaluation of Tailored Messages to Address Parental Questions About HPV Vaccination

Who this might be right for
Human Papilloma Virus VaccinesAttitude to Health
Indiana University 908
Very early researchEnded earlyNCT02827838
What this trial is testing

Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer

Who this might be right for
Human Papillomavirus InfectionStage I Oral Cavity Squamous Cell CarcinomaStage I Oropharyngeal Squamous Cell Carcinoma+9 more
Wake Forest University Health Sciences 17
Large-scale testing (Phase 3)Study completedNCT00652938
What this trial is testing

Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine Co-administered With Another Vaccine in Healthy Female Subjects

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 744
Large-scale testing (Phase 3)WithdrawnNCT02100618
What this trial is testing

Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline
Not applicableStudy completedNCT03542513
What this trial is testing

First-void Urine Samples for the Follow-up of Women Treated for High-grade Cervical Intraepithelial Neoplasia (CIN)

Who this might be right for
Cervical Cancer
Universiteit Antwerpen 65
Testing effectiveness (Phase 2)Looking for participantsNCT05419089
What this trial is testing

The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)

Who this might be right for
HPV-positive Oropharyngeal Squamous Cell Carcinoma
Icahn School of Medicine at Mount Sinai 83
Testing effectiveness (Phase 2)Study completedNCT01432574
What this trial is testing

Study of Gardasil in Mid-Adult Males (MAM)

Who this might be right for
Human Papillomavirus
H. Lee Moffitt Cancer Center and Research Institute 150
Post-approval studies (Phase 4)Looking for participantsNCT07668271
What this trial is testing

Lot-to-Lot Consistency Clinical Trial of Recombinant Human Papillomavirus 9-valent (Types 6/11/16/18/31/33/45/52/58) Vaccine (Escherichia Coli)

Who this might be right for
Infection by Human Papilloma Virus
Xiamen Innovax Biotech Co., Ltd 720
Testing effectiveness (Phase 2)Active Not RecruitingNCT06223568
What this trial is testing

Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckOropharynxHuman Papillomavirus Viruses+2 more
National Cancer Institute (NCI) 70
Not applicableUnknownNCT05233540
What this trial is testing

Circulating Biomarkers in Patients With Anal Cancer Treated With Induction Chemotherapy

Who this might be right for
Anal CancerLocally Advanced Squamous Cell CarcinomaOligometastatic Disease+2 more
Aarhus University Hospital 60
Testing effectiveness (Phase 2)Study completedNCT04247282
What this trial is testing

Anti-PD-L1/TGF-beta Trap (M7824) Alone and in Combination With TriAd Vaccine and N-803 for Resectable Head and Neck Squamous Cell Carcinoma Not Associated With Human Papillomavirus Infection

Who this might be right for
Head and Neck CancerHead and Neck Neoplasms
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)UnknownNCT04650711
What this trial is testing

Immunohistochemical Staining of p16 for the Screening of Cervical Cancer

Who this might be right for
Cervical Cancer Screeningp16 ProteinCytology+4 more
Lei Li 250
Not applicableStudy completedNCT05756192
What this trial is testing

Educational Video's Impact on Knowledge Regarding Cervical Cancer Screening

Who this might be right for
Human Papilloma VirusCervical Dysplasia
George Washington University 200
Testing effectiveness (Phase 2)Study completedNCT01807546
What this trial is testing

Oral Rigosertib for Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaAnal Squamous Cell CarcinomaLung Squamous Cell Carcinoma+4 more
Traws Pharma, Inc. 64
Early research (Phase 1)Ended earlyNCT03634267
What this trial is testing

MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer

Who this might be right for
Human Papillomavirus-Related CarcinomaHuman Papillomavirus-Related Cervical CarcinomaStage IB2 Cervical Cancer AJCC v8+14 more
M.D. Anderson Cancer Center 26
Large-scale testing (Phase 3)Study completedNCT01462357
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 1,079
Next Page